Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Case definition for progressive multifocal leukoencephalopathy following treatment with monoclonal antibodies.

Mentzer D, Prestel J, Adams O, Gold R, Hartung HP, Hengel H, Kieseier BC, Ludwig WD, Keller-Stanislawski B.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):927-33. doi: 10.1136/jnnp-2012-302478. Epub 2012 Jul 17.

PMID:
22807558
2.

JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.

McGuire D, Barhite S, Hollander H, Miles M.

Ann Neurol. 1995 Mar;37(3):395-9. Erratum in: Ann Neurol 1995 May;37(5):687.

PMID:
7695239
3.

A rational approach to PML for the clinician.

Calabrese L.

Cleve Clin J Med. 2011 Nov;78 Suppl 2:S38-41. doi: 10.3949/ccjm.78.s2.09.

4.

[Clinical characteristics, diagnostic criteria and treatment of progressive multifocal leukoencephalopathy].

Kuroda Y, Kosugi M.

Nihon Rinsho. 2007 Aug;65(8):1501-5. Review. Japanese.

PMID:
17695291
5.

Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy.

Nakamichi K, Inoue N, Shimokawa T, Kurane I, Lim CK, Saijo M.

BMC Neurol. 2013 Dec 13;13:200. doi: 10.1186/1471-2377-13-200.

6.

Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in Japan.

Nakamichi K, Mizusawa H, Yamada M, Kishida S, Miura Y, Shimokawa T, Takasaki T, Lim CK, Kurane I, Saijo M.

BMC Neurol. 2012 Oct 15;12:121. doi: 10.1186/1471-2377-12-121.

7.

Review of progressive multifocal leukoencephalopathy and natalizumab.

Aksamit AJ.

Neurologist. 2006 Nov;12(6):293-8. Review.

PMID:
17122725
8.

[Progressive multifocal leukoencephalopathy (PML). Report of a case diagnosed by amplification of JC virus DNA from cerebrospinal fluid (CSF)].

Ito D, Yogo Y, Okita H, Tanaka K, Koto A.

Rinsho Shinkeigaku. 1998 Jan;38(1):46-50. Japanese.

PMID:
9597910
9.

Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid.

Weber T, Turner RW, Frye S, Lüke W, Kretzschmar HA, Lüer W, Hunsmann G.

AIDS. 1994 Jan;8(1):49-57.

PMID:
8011236
10.

[Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].

Kishida S.

Brain Nerve. 2007 Feb;59(2):125-37. Review. Japanese.

PMID:
17380777
11.

Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid: diagnostic value for progressive multifocal leukoencephalopathy.

Sugimoto C, Ito D, Tanaka K, Matsuda H, Saito H, Sakai H, Fujihara K, Itoyama Y, Yamada T, Kira J, Matsumoto R, Mori M, Nagashima K, Yogo Y.

Arch Virol. 1998;143(2):249-62.

PMID:
9541611
12.

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C.

N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.

13.

Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy.

Salmaggi A, Maccagnano E, Castagna A, Zeni S, Fantini F, Cinque P, Savoiardo M.

Neurol Sci. 2001 Feb;22(1):17-20.

PMID:
11487186
14.

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.

Bossolasco S, Calori G, Moretti F, Boschini A, Bertelli D, Mena M, Gerevini S, Bestetti A, Pedale R, Sala S, Sala S, Lazzarin A, Cinque P.

Clin Infect Dis. 2005 Mar 1;40(5):738-44. Epub 2005 Feb 1.

PMID:
15714422
15.

[Progressive multifocal leukoencephalopathy confirmed by PCR for JC virus in cerebrospinal fluid: case report].

Pasqualotto AC, de Mattos AJ, Rocha MM.

Arq Neuropsiquiatr. 2004 Jun;62(2B):550-4. Epub 2004 Jul 20. Review. Portuguese.

16.

Mefloquine improved progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.

Beppu M, Kawamoto M, Nukuzuma S, Kohara N.

Intern Med. 2012;51(10):1245-7. Epub 2012 May 15.

17.

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy.

Yousry TA, Major EO, Ryschkewitsch C, Fahle G, Fischer S, Hou J, Curfman B, Miszkiel K, Mueller-Lenke N, Sanchez E, Barkhof F, Radue EW, Jäger HR, Clifford DB.

N Engl J Med. 2006 Mar 2;354(9):924-33.

18.

Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

Lindå H, von Heijne A, Major EO, Ryschkewitsch C, Berg J, Olsson T, Martin C.

N Engl J Med. 2009 Sep 10;361(11):1081-7. doi: 10.1056/NEJMoa0810316.

19.

Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.

Kobayashi Z, Akaza M, Numasawa Y, Ishihara S, Tomimitsu H, Nakamichi K, Saijo M, Morio T, Shimizu N, Sanjo N, Shintani S, Mizusawa H.

J Neurol Sci. 2013 Jan 15;324(1-2):190-4. doi: 10.1016/j.jns.2012.11.004. Epub 2012 Nov 22.

PMID:
23182496
20.

Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB.

J Clin Microbiol. 1995 Feb;33(2):484-6.

Supplemental Content

Support Center